Ten adult patients (age < 20 years (n = 3), concomitant other cancers (follicular lymphoma, earlier ACC and breast cancer, lung adenocarcinoma, prostate cancer (n = 4)) or strong family history of cancer (n = 3)) were screened for germline TP53 gene mutations, all were negative. This evidence concerns the gene TP53 and prostate carcinoma.